DE-105

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameDE-105
Drug Alias NameRU-105DE-105
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionBeta-nerve growth factor stimulants
TargetsBeta-nerve growth factor
Therapy Area/IndicationsPersistent corneal epithelial defect
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanten Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanten Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsPersistent corneal epithelial defect

Other Information

ATC CodeN/A
Related LinksN/A